RGNT Latest Press Releases

-- June 17, 2026 --

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement ACCESS Newswire 9:06 PM

-- June 8, 2026 --

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate ACCESS Newswire 8:32 AM

-- April 16, 2026 --

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon ACCESS Newswire 8:30 AM

-- March 17, 2026 --

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400% ACCESS Newswire 8:30 AM

-- February 24, 2026 --

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update ACCESS Newswire 4:15 PM

-- February 19, 2026 --

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair ACCESS Newswire 8:30 AM

-- February 17, 2026 --

Regentis Expands its European Clinical Site Network to Support its Commercial and Clinical Programs ACCESS Newswire 8:30 AM

-- February 4, 2026 --

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial ACCESS Newswire 8:33 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software